The role of short-term tests of reversibility in selecting patients with COAD for long-term
nebuliser therapy is uncertain. In a double-blind placebo-controlled crossover study we …

One-hundred nebulizer trials were performed in 98 adult patients with chronic airflow
limitation who had remained symptomatic despite regular use of bronchodilators by metered …

In steroid resistant chronic obstructive pulmonary disease (COPD) we assessed the effect of
qid domiciliary nebulized fenoterol (F) 1.25 mg and ipratropium (I) 0.5 mg for three weeks in …

Background: A limited or absent bronchodilator response is used to classify chronic
obstructive pulmonary disease (COPD) and can determine the treatment offered. The …

Spirometry before and after an inhaled beta agonist or a course of oral prednisolone is
widely used to detect reversible airflow limitation in patients with chronic obstructive lung …

The difficulty of assessing nebulizer responses in chronic obstructive pulmonary disease
(COPD) has been demonstrated before. This study aims to re-examine both the role of …

Categorization of patients with COPD as reversible or nonreversible to a bronchodilator may
change over time. This post hoc analysis aimed to determine if an individual's reversibility …

Background and aims: Bronchodilator reversibility (BDR) and inhaled corticosteroid (ICS)
use were assessed for volunteers who responded to an advertisement requesting current or …

BACKGROUND Bronchodilator reversibility testing is recommended in all patients with
chronic obstructive pulmonary disease (COPD) but does not predict improvements in …

The assessment of reversibility is recognized as being an essential part of the management
of airways obstruction, but testing for reversibility of airways obstruction may not be useful for …